Lv1
40 积分 2026-04-12 加入
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
18小时前
待确认
R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model
5天前
已完结
皖公网安备34019202002308
